Summary:
Local doctors are recruiting participants to help them learn more about an investigational drug, Olokizumab, for difficult to treat Rheumatoid Arthritis through clinical research.
Qualified Participants Must:
• Be 18 years old or older with a diagnosis of Rheumatoid Arthritis
•
Currently being treated with Methotrexate
•
Have sore, swollen joints and have received Methotrexate or a biologic drug, but have not experienced adequate relief of symptoms
Qualified Participants May Receive:
Study-related medication and study-related care will be provided to qualified participants. Compensation will be given to qualified participants.